Clinical Trial Update: Disease Modifying Therapies Withdrawal in Inactive Relapsing-remitting Multiple Sclerosis Patients Aged 55 and Over (TWINS : Therapies Withdrawal IN Relapsing Multiple Sclerosis) [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial (TWINS) evaluating withdrawal of disease-modifying therapies in inactive Relapsing-remitting Multiple Sclerosis patients aged 5…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Relapsing-remitting Multiple Sclerosis (RRMS) | Phase 3 | Status: NOT_YET_RECRUITING